Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:43 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 417 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Diabetic Ulcers Clear all

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Chronic Foot Ulcer
Interventions: Symphony™ plus Off-loading, Wound Dressing comprising of calcium alginate Fibracol; Device
Lead sponsor: Aroa Biosurgery Limited; Industry
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 11
States / cities: Los Angeles, California • San Francisco, California • Miami, Florida + 7 more

Conditions: Chronic Ulcer of Lower Extremity
Interventions: PalinGen Flow Amniotic Tissue Allograft; Biological
Lead sponsor: Amnio Technology, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 7
States / cities: Carmichael, California • Castro Valley, California • Fresno, California + 4 more

Conditions: Diabetic Foot Ulcer, Venous Ulcer
Interventions: Low Frequency, Low Intensity Ultrasound, Sham Applicator; Device
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetic Foot Ulcers, Pressure Ulcers
Interventions: HP828-101, Hydrogel/Hydrocolloid; Device
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 11
States / cities: Bakersfield, California • Chula Vista, California • Fresno, California + 7 more

Conditions: Ulcer Healing, Diabetic Foot Ulcer
Interventions: human keratin graft; Device
Lead sponsor: ProgenaCare Global, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 3
States / cities: Miami, Florida • Frederick, Maryland • Salem, Virginia

Conditions: Chronic Wounds, Diabetes, Venous Stasis Ulcers
Interventions: FGF-1; Drug
Lead sponsor: Venturis Therapeutics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Warren, Pennsylvania

Conditions: Lower Extremity Chronic Ulcers in Diabetics, Diabetic Foot Ulcer (DFU)
Interventions: amniotic membrane; Other
Lead sponsor: Tides Medical; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 5
States / cities: North Port, Florida • Buffalo, New York • Monroeville, Pennsylvania + 2 more

Conditions: Chronic Ulcers, Diabetic Foot Ulcers (DFU), DFU, Ulcer
Interventions: Corplex P is used to cover, protect, and provide a moist wound environment; Device
Lead sponsor: StimLabs; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Bridgeport, Connecticut

Conditions: Diabetic Foot Ulcer
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 5
States / cities: Palo Alto, California • San Francisco, California • Miami, Florida + 2 more

Conditions: Chronic Wounds With Different Etiologies
Interventions: Swabs; Other
Lead sponsor: Systagenix Wound Management; Industry
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Diabetic Foot Ulcer
Interventions: 0.03% DSC127 topical gel; Drug
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 21
States / cities: Mobile, Alabama • Chino, California • Fresno, California + 16 more

Conditions: Diabetic Foot, Ulcer Foot
Interventions: no interventions; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Diabetic Foot Ulcer, Pressure Injury, Pressure Ulcer
Interventions: Invia Motion Endure; Device
Lead sponsor: Medela AG; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Diabetic Foot Ulcer
Interventions: dermaPACE; Device
Lead sponsor: SANUWAVE, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Diabetic Foot Ulcer
Interventions: ALLO-ASC-SHEET; Biological
Lead sponsor: Anterogen Co., Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Diabetic Foot Ulcer, Type 2 Diabetes
Interventions: Specimen Collection; Other
Lead sponsor: Winthrop University Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Diabetic Foot Ulcer
Interventions: Lavior Diabetic Wound Gel, Smith & Nephew Solosite Gel Hydrogel Wound Dressing; Drug
Lead sponsor: Lavior Pharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Diabetic Foot Ulcer
Interventions: MIST Therapy, SOC - Standard of Care; Device · Other
Lead sponsor: Celleration, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Diabetic Foot Ulcers, Osteomyelitis
Interventions: DFU; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Diabetic Foot Ulcer
Interventions: AutoloGel, Usual and Customary Care; Device · Other
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Hattiesburg, Mississippi

Conditions: Diabetic Foot
Interventions: SkinTE, Control; Biological · Other
Lead sponsor: PolarityTE; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 13
States / cities: Fresno, California • Los Angeles, California • Hollywood, Florida + 8 more

Conditions: Diabetic Neuropathies, Diabetic Foot, Diabetic Retinopathy
Interventions: no intervention; Other
Lead sponsor: VisionQuest Biomedical LLC; Industry
Eligibility: 35 Years to 76 Years
Enrollment: 331 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Diabetic Foot Infections
Interventions: Bisphosphocin Nu-3, Placebo; Drug
Lead sponsor: Lakewood-Amedex Inc; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: San Francisco, California • Oldsmar, Florida • Franklin, Tennessee

Conditions: Type II Diabetes
Interventions: Sitagliptin, Placebo; Drug
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.

Clinical Study Evaluating Symphony™ Versus Standard of Care in the Treatment of Non-Healing Diabetic Foot Ulcers

Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities

Enhanced Ultrasound Treatment of Chronic Wounds With Monitoring of Healing and Quality of Life Outcomes

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

Evaluating The Efficacy Of A Keratin Graft In Treating Non-Healing Diabetic Foot Ulcers

FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.

Case Series of StimLabs Dehydrated Human Umbilical Cord Particulate for Acute and Chronic Wounds

Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials

Swab Sample Collection for the Detection of Bacterial Proteases in Wounds Assay

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

Diabetic Foot Ulcer Recurrence: Pilot Study

Evaluating Clinical Acceptance of a NPWT Wound Care System

The Effects of High Energy Acoustic Shock Wave Therapy on Local Skin Perfusion and DFUs

Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers

Development of a Cellular Biomarker for the Diagnosis and Treatment of Diabetic Foot Ulcers

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs

UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository

Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.

Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs

Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)

Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus

Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers